Detalhe da pesquisa
1.
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.
Lancet
; 402(10415): 1835-1847, 2023 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871608
2.
Performance of Noninvasive Tests of Fibrosis Among Asians, Hispanic, and non-Hispanic Whites in the STELLAR Trials.
Clin Gastroenterol Hepatol
; 21(1): 90-102.e6, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35074532
3.
ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related Cirrhosis.
Clin Gastroenterol Hepatol
; 21(9): 2278-2287.e5, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36375797
4.
Predictive Performance of CAGE-B and SAGE-B Models in Asian Treatment-Naive Patients Who Started Entecavir for Chronic Hepatitis B.
Clin Gastroenterol Hepatol
; 20(4): e794-e807, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34091048
5.
Long-term effects of entecavir and tenofovir treatment on the fibrotic burden in patients with chronic hepatitis B.
J Gastroenterol Hepatol
; 37(1): 200-207, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34478195
6.
Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir.
J Viral Hepat
; 28(1): 95-104, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33029863
7.
Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study.
Dig Dis Sci
; 66(7): 2427-2438, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32856240
8.
Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients.
J Korean Med Sci
; 36(16): e105, 2021 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33904261
9.
Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy.
Clin Gastroenterol Hepatol
; 18(3): 693-699.e1, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31252188
10.
A multi-centre study of trends in hepatitis B virus-related hepatocellular carcinoma risk over time during long-term entecavir therapy.
J Viral Hepat
; 27(12): 1352-1358, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32852880
11.
Predictive score for hepatocellular carcinoma after hepatitis B e antigen loss in patients treated with entecavir or tenofovir.
J Viral Hepat
; 27(10): 1052-1060, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32383246
12.
A Model to Predict 1-Month Risk of Transplant or Death in Hepatitis A-Related Acute Liver Failure.
Hepatology
; 70(2): 621-629, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30194739
13.
Changes in Characteristics of Patients with Liver Cirrhosis Visiting a Tertiary Hospital over 15 Years: a Retrospective Multi-Center Study in Korea.
J Korean Med Sci
; 35(29): e233, 2020 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32715667
14.
Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma.
Int J Cancer
; 144(6): 1444-1452, 2019 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30338850
15.
A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea.
J Hepatol
; 71(3): 456-464, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30959156
16.
Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia.
Gastroenterology
; 155(3): 705-718, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29778606
17.
Long-term Outcomes of Antiviral Therapy in Patients With Advanced Chronic HBV Infection.
Clin Gastroenterol Hepatol
; 17(13): 2811-2813.e1, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30731195
18.
Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis.
Dig Dis Sci
; 64(1): 285-286, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30324553
19.
Effects of Virologic Response to Treatment on Short- and Long-term Outcomes of Patients With Chronic Hepatitis B Virus Infection and Decompensated Cirrhosis.
Clin Gastroenterol Hepatol
; 16(12): 1954-1963.e3, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29753085
20.
Phase I/II study of first-line combination therapy with sorafenib plus resminostat, an oral HDAC inhibitor, versus sorafenib monotherapy for advanced hepatocellular carcinoma in east Asian patients.
Invest New Drugs
; 36(6): 1072-1084, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30198057